New perspectives on the role of muscarinic antagonists in asthma therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

New perspectives on the role of muscarinic antagonists in asthma therapy

Published:2020-04-26 Issue:8 Volume:14 Page:817-824
ISSN:1747-6348
Container-title:Expert Review of Respiratory Medicine
language:en
Short-container-title:Expert Review of Respiratory Medicine

Author:

Matera Maria Gabriella¹,Belardo Carmela¹,Rinaldi Michele²,Rinaldi Barbara¹,Cazzola Mario³^ORCID

Affiliation:

1. Unit of Pharmacology, Department of Experimental Medicine, University of Campania “Luigi Vanvitelli”, Naples, Italy

2. Multidisciplinary Department of Medical-Surgical and Dental Specialities, University of Campania “Luigi Vanvitelli”, Naples, Italy

3. Unit of Respiratory Medicine, Department of Experimental Medicine, University of Rome “Tor Vergata”, Rome, Italy

Funder

not funded

Publisher

Informa UK Limited

Subject

Public Health, Environmental and Occupational Health,Pulmonary and Respiratory Medicine,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/17476348.2020.1758069

Reference73 articles.

1. Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline

2. Tiotropium in asthma: what is the evidence and how does it fit in?

3. Tiotropium in the add-on treatment of asthma in adults: clinical trial evidence and experience

4. Tiotropium for the treatment of asthma in adolescents

5. Tiotropium add-on to inhaled corticosteroids versus addition of long-acting β2-agonists for adults with asthma

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revisiting asthma pharmacotherapy: where do we stand and where do we want to go?;European Respiratory Journal;2023-07-20

2. Open-inhaler versus single-inhaler triple therapy (long-acting muscarinic antagonist, inhaled corticosteroid, and long-acting β₂-agonist) in asthma patients: a narrative review;Journal of Asthma;2023-04-23

3. Clinical characteristics, treatment patterns and adherence in patients with asthma on multiple inhaler triple therapy: a review of findings;Expert Review of Respiratory Medicine;2022-11-02

4. Optimizing asthma management: Role of long-acting muscarinic antagonists;Journal of Allergy and Clinical Immunology;2022-09

5. An update on the currently available and emerging synthetic pharmacotherapy for uncontrolled asthma;Expert Opinion on Pharmacotherapy;2022-06-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3